Resolvin E1 and E3 dampens asthmatic inflammation in a murine model

M. Sato (Gunma, Japan), H. Aoki-Saito (Gunma, Japan), M. Yatomi (Gunma, Japan), H. Tsurumaki (Gunma, Japan), Y. Koga (Gunma, Japan), N. Sunaga (Gunma, Japan), T. Maeno (Gunma, Japan), K. Dobashi (Gunma, Japan), S. Shuto (Hokkaido, Japan), M. Yamada (Gunma, Japan), T. Hisada (Gunma, Japan)

Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Session: Scientific advances in airway pharmacology
Session type: E-poster session
Number: 3299
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Sato (Gunma, Japan), H. Aoki-Saito (Gunma, Japan), M. Yatomi (Gunma, Japan), H. Tsurumaki (Gunma, Japan), Y. Koga (Gunma, Japan), N. Sunaga (Gunma, Japan), T. Maeno (Gunma, Japan), K. Dobashi (Gunma, Japan), S. Shuto (Hokkaido, Japan), M. Yamada (Gunma, Japan), T. Hisada (Gunma, Japan). Resolvin E1 and E3 dampens asthmatic inflammation in a murine model. 3299

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Resolvin E3 dampens asthmatic inflammation in a murine model through IL-23 pathway
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019



Resolvin D1 attenuates lung inflammation in LPS induced-ALI partly through PPARγ/NF-κB pathway
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011

Anti-inflammatory and anti-asthmatic effects of resolvin E1 in a mouse model of allergic asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


Resolvin E3 attenuates House Dust Mite (HDM) -induced asthmatic inflammation in a murine model
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018

Resolvin E3 reduces profibrotic factor production from macrophages leading to tissue homeostasis
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020


Antigen-induced formation of prostaglandin D2 in mouse asthma model
Source: Eur Respir J 2005; 26: Suppl. 49, 578s
Year: 2005

Narirutin inhibits airway inflammation in an allergic mouse model
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Downregulation of prostaglandin E2 in bronchial fibroblasts of asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002

A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010

Activated protein C inhibits bronchial inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 618s
Year: 2002

A novel protective role of prostaglandin D2 in antigen-induced bronchoconstriction
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020


Absence of proton-sensing TDAG8 protects against ovalbumin-induced allergic airway inflammation
Source: International Congress 2017 – New insights into pathogenesis of lung disease 
Year: 2017


Prostaglandin E2 suppresses the function of human group 2 innate lymphoid cells
Source: International Congress 2018 – Roles of innate lymphoid cells in asthma
Year: 2018


Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007

Relationships between glutaredoxin 1 and cytokine levels in a murine model of allergic airway inflammation
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002

EP4 agonist increases myeloid derived suppressor cells activity and reduces airway inflammatory events in a murine model of asthma
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020


Estrogen protects against airway inflammation via upregulation of SLPI and downregulation of IL-33
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012

Overexpression of suppressor of cytokine signaling-5 augments eosinophilic inflammation in an asthma model
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004

A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002